Viewing Study NCT02588456

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:20 PM

Ignite Modification Date: 2026-01-03 @ 7:39 AM

Study NCT ID: NCT02588456

Status: TERMINATED

Last Update Posted: 2023-06-22

First Post: 2015-10-26

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Sponsor: University of Pennsylvania

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module